Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/28/1996 | EP0727997A1 Pharmaceutical emulsion |
08/28/1996 | EP0727996A1 Fenbendazole formulations |
08/28/1996 | EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
08/28/1996 | EP0727994A1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac |
08/28/1996 | EP0727993A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds |
08/28/1996 | EP0727992A1 2'- and/or 7- substituted taxoids |
08/28/1996 | EP0727991A1 Compositions containing zinc linoleate for the treatment of skin disorders |
08/28/1996 | EP0727990A1 Compounds, compositions and treatment of allergies and inflammation |
08/28/1996 | EP0727989A1 Butyric ester cyto-differentiating agents |
08/28/1996 | EP0727988A1 Aids prophylactic lubricating composition and devices for its use |
08/28/1996 | EP0727987A1 Inhibition of respiratory burst using posttranslational modification inhibitors |
08/28/1996 | EP0727986A1 Treatment of migraine |
08/28/1996 | EP0727985A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
08/28/1996 | EP0727984A1 Controlled release preparation |
08/28/1996 | EP0727983A1 Process for preparing a clodronate preparation |
08/28/1996 | EP0727981A1 Antiperspirants and method of applying antiperspirant using a shaped article |
08/28/1996 | EP0727979A1 Novel composition |
08/28/1996 | EP0727978A1 Topical aromatic releasing compositions |
08/28/1996 | EP0727947A1 New beverage |
08/28/1996 | EP0727942A1 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds |
08/28/1996 | EP0727941A1 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds |
08/28/1996 | EP0678026B1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes |
08/28/1996 | EP0621862B1 Organic salts of n, n'-diacetyl cystine |
08/28/1996 | EP0593567B1 Use of substituted pyridazines against dermatosis |
08/28/1996 | EP0582711B1 Ketotricyclo(5.2.1.0)decane derivates |
08/28/1996 | EP0565519B1 Illudin analogs as anti-tumor agents |
08/28/1996 | EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth |
08/28/1996 | EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity |
08/28/1996 | EP0420872B1 Therapeutic uses of 2',5'-oligoadenylate derivatives |
08/28/1996 | EP0397697B1 Quinoline derivatives as antagonists of leukotriene d 4? |
08/28/1996 | CN1129943A Vasoconstrictive substituted dihydropyranopyridines |
08/28/1996 | CN1129942A Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity |
08/28/1996 | CN1129941A Substituted azaindolylidene compounds and process for their preparation |
08/28/1996 | CN1129940A Bicyclic tetrahydro pyrazolopyridines |
08/28/1996 | CN1129939A Pharmacologically active enantiomers |
08/28/1996 | CN1129938A Alkoxy-substituted beta-carbolines acting on the ampa-receptor |
08/28/1996 | CN1129937A Indoline derivatives as 5HT2C antagonists |
08/28/1996 | CN1129935A Vasoconstrictive substituted aryloxyalkyl diamines |
08/28/1996 | CN1129934A Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same |
08/28/1996 | CN1129933A 5-arylindole derivatives |
08/28/1996 | CN1129932A Salmeterol kinafoate with controlled particular size |
08/28/1996 | CN1129908A Therapeutic agent |
08/28/1996 | CN1129907A Inhibition of smooth muscle cell migration by (R)-amlodipine |
08/28/1996 | CN1129906A Use of N-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments |
08/28/1996 | CN1129905A Iontophoretic delivery of an antimigraine drug |
08/28/1996 | CN1129702A Imidazopyridines |
08/28/1996 | CN1129701A New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them |
08/28/1996 | CN1129698A Oxazolidinedione derivatives, their production and use |
08/28/1996 | CN1129697A New 5-(aryloxymethyl) oxazolines, a process for the preparation thereof and pharmaceutical compositions containing them |
08/28/1996 | CN1129581A Formulation type of medicine for relieving inflammation and pain and preparation thereof |
08/28/1996 | CN1129573A Skin absorptive antiviral drug |
08/28/1996 | CN1032650C Thiourea derivatives and antimicrobial agent and antiulcer agent containing same |
08/28/1996 | CN1032648C Process for preparation of platelet activating factor antagonist |
08/28/1996 | CA2170222A1 Use of quinoxalines in combination with protease inhibitors as medicaments for treating aids and/or hiv infections |
08/27/1996 | USRE35321 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
08/27/1996 | US5550262 Treatment of muscles wasting diseases |
08/27/1996 | US5550261 Taxoids, their preparation and pharmaceutical compositions containing them |
08/27/1996 | US5550259 Dicitrate cyclic diester can be used to prevent or reduce the effects of calcification-related disease |
08/27/1996 | US5550255 Intermediates for angiotensin converting enzyme inhibitors |
08/27/1996 | US5550254 Reacting carboxylic acid with carbonyldiimidazole or thiocarbonyldiimidazole, adding phenol or thiophenol compound |
08/27/1996 | US5550253 Reacting phenol or thiophenol derivative with lower alkyl p-toluenesulfonate, optionally reducing nitro groups to amino groups and acylating or alkylating them |
08/27/1996 | US5550247 1-alkyl-, 1-alkenyl-, and 1-alkynlaryl-2-amino-1, 3-propanediols and related compounds |
08/27/1996 | US5550245 3-quinolyl-substituted dihydropyridines, processes for their preparation and their use in medicaments |
08/27/1996 | US5550243 B preparation of 2- and 3- azido derivates of 1,5-iminosugars |
08/27/1996 | US5550240 For inhibiting lipid peroxidation after brain or spinal column injuries |
08/27/1996 | US5550239 Reacting trialkylsilyl n-pentylpiperazinylpyrimidine derivative with 4-amino-3-iodo-benzenesulfonamide compound in palladium catalyzed heteroannulation step, removing trialkylsilyl group with mineral acid, basifying |
08/27/1996 | US5550232 Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem 4-carboxylate |
08/27/1996 | US5550231 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
08/27/1996 | US5550225 Reacting an acid in presence of a base with an alkyl chloroformate to form mixed anhydride, reacting formed anhydride with d-maltose in an organic solvent, evaporating solvent, performing liquid/liquid extraction |
08/27/1996 | US5550166 Pinitol and derivatives thereof for the treatment of metabolic disorders |
08/27/1996 | US5550165 Containing 4-hydroxyphenylpyruvate dioxygenase inhibiting amount of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione |
08/27/1996 | US5550164 Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
08/27/1996 | US5550162 N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide derivatives, their preparation and their therapeutic use |
08/27/1996 | US5550161 Compounds which chelate iron and aluminum ions; treatment of various anemias, hemosiderosis, alzheimer*s disease |
08/27/1996 | US5550158 Method of treating wrinkles using glucoheptonic acid |
08/27/1996 | US5550156 Blending docosahexaenoic acid containing microbial oil, a gamma linolenic acid containing oil, adding to infant formula |
08/27/1996 | US5550155 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures |
08/27/1996 | US5550154 Topical application |
08/27/1996 | US5550152 Antiinflammatory agents |
08/27/1996 | US5550151 Methods of reducing scarring in wound healing |
08/27/1996 | US5550150 Using a benzothiophene compound |
08/27/1996 | US5550149 Sulfur-containing compounds that are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing sensitivity of multi-drug resistant cells |
08/27/1996 | US5550145 Bactericides or fungicides as preservatives for cosmetics |
08/27/1996 | US5550144 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
08/27/1996 | US5550143 Heterocyclic compounds |
08/27/1996 | US5550142 Phenyl heterocycles as cox-2 inhibitors |
08/27/1996 | US5550139 Serine protease inhibitors |
08/27/1996 | US5550136 Methanoanthrancenyl piperidyl antipsychotics |
08/27/1996 | US5550135 Heterocycle-substituted benzenemethanamine derivatives |
08/27/1996 | US5550134 Administering to a mammal from a series of benzoquinolin-3-one compounds |
08/27/1996 | US5550133 Carbamates of rapamycin |
08/27/1996 | US5550132 Treating septic shock, cachexia, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, aids |
08/27/1996 | US5550130 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl)piperidines and related compounds and their therapeutic utility |
08/27/1996 | US5550129 Benzopyranones, processes for their preparation and their use |
08/27/1996 | US5550127 Administering angiotensin converting enzyme inhibitor to treat exercise-induced pulmonary hemorrhage in non-human mammals |
08/27/1996 | US5550126 Psychological disorders, drug withdrawal |
08/27/1996 | US5550125 Brain disorders |
08/27/1996 | US5550124 Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
08/27/1996 | US5550123 Methods for inhibiting bone prosthesis degeneration |
08/27/1996 | US5550120 Regulating neuropeptide hormone secretion |